Related Experiment Video
Updated: Jun 13, 2026

Generation and 3-Dimensional Quantitation of Arterial Lesions in Mice Using Optical Projection Tomography
Published on: May 26, 2015
[Open surgery for femoro-popliteal arterial occlusive disease]
Peng Liu1, Zhi-dong Ye, Xue-qiang Fan
1Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
Insights
Artificial prosthesis bypass offers favorable mid-term results for femoro-popliteal arterial occlusive disease (TASC II type C and D lesions). This arterial revascularization technique demonstrates a high primary patency rate, making it a key treatment option.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Context:
- Femoro-popliteal arterial occlusive disease significantly impacts patient mobility and quality of life.
- TASC II classifications C and D represent complex lesions requiring effective revascularization strategies.
- Evaluating mid-term surgical outcomes is crucial for optimizing treatment protocols.
Purpose:
- To assess the mid-term surgical results of arterial revascularization for femoro-popliteal arterial occlusive disease, specifically TASC II type C and D lesions.
- To compare the efficacy of different revascularization techniques, including autogenous vein grafts and artificial prostheses.
Summary:
- A study of 191 arterial bypass procedures in 170 patients with TASC II type C (127 limbs) and D (64 limbs) lesions was conducted.
- Artificial prosthesis revascularization showed a primary patency rate of 88.2%, compared to 70.8% for greater saphenous vein grafts.
- The overall primary patency rate was 84.4% at a mean follow-up of 24 months, with no 30-day mortality.
Impact:
- Arterial revascularization with artificial prosthesis is a primary treatment for complex femoro-popliteal occlusive disease.
- These findings support the use of artificial grafts for improved limb salvage and patient outcomes.
- The study highlights the importance of graft material selection in achieving successful long-term revascularization.
Objective:
To explore the mid-term surgical results of arterial revascularization for femoro-popliteal arterial occlusive disease (lesion type C and D).
Methods:
From January 2005 to February 2009, 191 arterial bypass had been performed on 170 patients (21 cases bilateral). There were 108 male and 62 female, age ranged from 45 to 85 years old with an average of 67 years old. The operative indication was claudication in 78 cases, rest pain in 62 cases, ischemic ulcer in 19 cases, and distal tissue necrosis in 11 cases. Arterial angiography were performed on all cases. According to TASC II document, type C lesions were seen in 127 limbs, type D lesions were seen in 64 limbs. Autogenous greater saphenous vein bypass in situ were done on 15 limbs, autogenous greater saphenous vein bypass reversed in 20 limbs, revascularization with artificial prosthesis in 128 limbs, composite grafts consisting of a prosthetic conduit with a distal venous segment in 28 limbs.
Results:
There were no 30-day mortality. Follow-up periods ranged 6 to 36 months with an average of (24 + or - 6) months. Seventy-three cases were lost during follow-up periods, follow-up rate was 57% (109/191). Primary patency rate was 84.4% (92/109). The patency rate was 88.2% with artificial prosthesis, 70.8% with greater saphenous vein (in situ or reversed). Secondary patency rate was 89.9%.
Conclusions:
Arterial revascularization with artificial prosthesis is main treatment for diffused superficial femoral artery occlusive disease (TASC II type C and D lesion) with satisfied surgical results.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Arteries of Lower Limbs
Peripheral Artery Disease IV: Nursing Management